BACKGROUND/OBJECTIVES: Cancer-focused organizations now recommend routine assessment of instrumental activities of daily living (iADLs) for all older patients with cancer, along with assessment of basic activities of daily living (ADLs) if possible. However, little is known regarding the role of iADLs in predicting survival and acute-care utilization in populations of older adults with different hematologic malignancies. DESIGN: Prospective cohort study. SETTING AND PARTICIPANTS: A screening geriatric assessment was conducted for adults 75 years and older with hematologic malignancies (n = 464) presenting for initial consultation at a large tertiary cancer hospital in Boston, MA. MEASUREMENTS: Univariable and multivariable analyses assessed the association of dependency in ADLs and dependency in iADLs with survival and care utilization (emergency department [ED] visits and unplanned hospitalizations). RESULTS: Subjects were a mean age of 79.7 years and had a mean follow-up of 13.8 months. Overall, 11.4% had dependency in ADLs and 26.7% had dependency in iADLs. Only iADL dependency was associated with higher mortality (hazard ratio = 2.34 [95% confidence interval [CI] = 1.46-3.74]) independently of age, comorbidity, cancer aggressiveness, and treatment intensity. The effect was dose dependent, and impairments in shopping, meal preparation,
D espite comprising the majority of patients with hematologic malignancies, older adults are underrepresented in the clinical trials that lead to new therapies for blood cancer. 1 Traditional methods in oncology used to assess performance status and treatment tolerability-such as the Eastern Cooperative Oncology Group Scale-are not optimal for identification of vulnerabilities associated with aging physiology, multimorbidity, and frailty. [2] [3] [4] [5] Indeed, the American Society of Clinical Oncology (ASCO) recently issued a guideline recommending that geriatric assessment replace or complement traditional performance status scales in the identification of older adults at increased risk for treatment toxicity, mortality, and other adverse outcomes. 6 Functional status, as measured by patient-reported dependency in basic activities of daily living (ADLs) and instrumental ADLs (iADLs), is a cornerstone of the geriatric assessment and has been associated with survival and other outcomes in older adults with cancer. 2, [7] [8] [9] [10] [11] [12] ADLs-activities necessary for independent self-care-have been linked to changes in treatment recommendations and mortality. 13 In particular, iADLs-activities necessary for an older adult to live independently in his/her community-have shown a consistent relationship with important outcomes across studies and cancer types, and accordingly were recommended by ASCO's guideline as the preferred measure of functional status. 6 Prior studies have evaluated the role of iADLs in small, specific populations of older adults with hematologic malignancies, such as older allogeneic hematopoietic cell transplantation (HCT) recipients and older patients with acute myeloid leukemia (AML) receiving induction chemotherapy. 14, 15 Moreover, iADLs have been linked to unplanned hospitalizations in older patients with ovarian cancer and other solid tumors. 9, 16 However, little is known regarding the role iADLs play in predicting survival and acute-care utilization in older patients with different hematologic malignancies, including the myelodysplastic syndromes (MDSs), leukemia, myeloma, and lymphoma.
We aimed to assess the association of functional status with survival and care utilization in adults aged 75 years and older diagnosed with hematologic malignancies. We hypothesized that functional dependency would correlate with both increased care utilization and higher mortality. We further explored whether dependency in iADLs interacts with social support, depression, cancer aggressiveness, and treatment intensity. We last assessed for associations between other geriatric assessment domains and iADL dependency to determine potential targets for intervention.
METHODS

Patient Population
Our cohort assembly methods are presented in detail elsewhere. 17 Briefly, all patients aged 75 years and older who presented for an initial consultation in the MDS/leukemia, myeloma, or lymphoma clinics of the Dana-Farber Cancer Institute (Boston, MA), between February 1, 2015, and November 15, 2017, were eligible for participation. We excluded patients referred for HCT consultation since these patients represent a different population typically with less frailty/vulnerability. Eligible patients who gave consent to be included in the study were approached by a research assistant who administered a screening geriatric assessment tool composed of patient-reported and objective measures. The remainder of the geriatric assessment variables, along with demographics, disease characteristics, and comorbidities, were obtained via chart review. All geriatric variables were measured on the day of initial consultation. The assistant was trained in the administration of the geriatric assessment tool by a board-certified geriatrician and was supervised before performing the test independently. After a brief waiting period, we contact all oncologists with the outcome of the assessment, and they are offered on-site geriatrician management if desired. The study was approved by the Dana-Farber/Harvard Cancer Center Office for the Protection of Human Research Subjects.
Patient-Reported Function
The ADLs assessed in our geriatric assessment tool included bathing, dressing, transferring, eating, grooming, and toileting (patient reported). The iADLs assessed included shopping, meals, housework, medications, and finances (patient reported). We did not assess the additional iADLs of driving, telephone use, and doing laundry to reduce participation burden. Patients were asked whether they were able to complete these activities independently, with assistance, or entirely dependent on others. Each activity for which patients answered needing assistance or dependent on others was categorized as dependent. Patients who were dependent in one or more ADLs were categorized as ADL dependent. Patients who were dependent in one or more iADLs were categorized as iADL dependent. These categorizations are consistent with ASCO's guidelines and prior research on ADLs and iADLs in older adults. 6, [18] [19] [20] 
Geriatric Assessment Variables
To assess for interacting variables and factors associated with iADL dependency, we measured other geriatric assessment domains, including cognition, comorbidity, physical function, and psychosocial vulnerability-defined as either patient-reported depression or loneliness. To assess patientreported depression, patients were asked, "How often do you feel depressed?" Patients who answered "some of the time" or "most of the time" were categorized as depressed, whereas those who answered "rarely" were categorized as not depressed. To assess patient-reported loneliness, patients were asked, "How often do you feel lonely?" Patients who answered "some of the time" or "most of the time" were categorized as lonely, whereas those who answered "rarely" were categorized as not lonely. Both of these measures were derived from the psychosocial component of the original frailty questionnaire by Searle et al. 21 We also recorded marital status-classified as currently married or "other" (including widowed), as a surrogate marker of social support. 22 Two cognitive domains were screened: (1) executive function via the Clock-in-the-Box (CIB) test 23 and (2) delayed memory via the five-word delayed recall list from the Montreal Cognitive Assessment (both objective measures). 24 Consistent with previous studies of the CIB test, we defined a score of less than 5 as probable impairment in executive function. We defined the ability to recall two or fewer words as probable impairment in delayed memory. We used gait speed as a single measure of physical function using the National Institutes of Health four-meter gait speed test (objective measure). 25 Patients with a gait speed of less than 0.8 m/s were classified as having physical dysfunction, consistent with prior studies. 26 We extracted chronic conditions from patients' charts and scored the severity of comorbidity via the Charlson Comorbidity Index. 27 
Disease Covariates
We extracted disease and treatment characteristics from chart review to include as covariates in our analyses. Hematologic malignancies were categorized as aggressive (diffuse large B-cell lymphoma, mantle cell lymphoma, multiple myeloma, AML) or indolent (marginal zone lymphoma, follicular lymphoma, chronic lymphocytic leukemia, monoclonal gammopathy of unknown significance, MDS, myeloproliferative neoplasm/myeloproliferative disease, and hairy-cell leukemia). 17, 28 Regarding treatment, patients were first categorized on whether they received treatment prior to enrollment ("prior treatment": yes or no). Next, current or new treatments ("current/new treatment") prescribed within 3 months after enrollment were categorized as intensive (eg, "RCHOP" and triplet therapy regimens for lymphoma and multiple myeloma, respectively), reduced intensity (eg, significantly dose-reduced chemotherapy or hypomethylating agents), or supportive (eg, surveillance or only receiving erythropoiesis-stimulating agents and/or blood transfusions). Treatment classification was confirmed by all authors, and any questions in treatment assignment were adjudicated by C.D. and G.A.
Outcome Measures: Survival and Care Utilization
Survival status with at least 6 months of follow-up was confirmed by a combination of chart review and calls to patients' primary care providers. For emergency department (ED) visits and unplanned hospitalizations, we identified a subset of patients who were consistently followed at our cancer hospital or other hospitals (community and academic) in our larger care system for at least 6 months following initial consultation. ED visits and unplanned hospitalizations were identified via chart review, excluding any planned admissions or elective procedures.
Statistical Analysis
Descriptive means and proportions were reported for baseline characteristics. Cox proportional hazards regression analyses were used to assess the association of ADL dependency and iADL dependency with survival-first via univariable analyses, followed by multivariable analyses adjusting for demographic (age and sex) and clinical (comorbidity, cancer aggressiveness, prior treatment, current/new treatment intensity) covariates. In the subset of patients followed in our care system, logistic regression was used to assess the association of ADL dependency and iADL dependency with unplanned ED visits and hospitalizations-first via univariable analyses, followed by multivariable analyses. We performed a sensitivity analysis to explore the possibility that patients who reported iADL dependency also had ADL dependency (Table SS1) .
In Figure 1 . Flow diagram depicting inclusion of patients in the study.
aggressiveness and treatment intensity to affect survival. We also assessed whether iADL dependency interacted with depression, loneliness, and marital status. Moreover, iADLs were analyzed individually and ordinally. Repeating the above multivariable survival analyses, the iADL dependency variable was first substituted with dependency in each of the five individual iADLs measured, and next with ordinal categories of increasing number of iADL dependencies (one, two, and three or more). As an exploratory analysis, we measured the cross-sectional association between iADL dependency and impairment in each geriatric assessment domain measured (cognition, comorbidity, physical function, psychosocial vulnerability) using Fisher's exact tests and multivariable logistic regression. Figure SS1 illustrates our hypothesized relationships among geriatric impairments, iADL dependency, and outcomes. Data were analyzed using SAS, version 9.4 (SAS Institute Inc, Cary, NC), and Stata software, version 15.1 (StataCorp, College Station, TX).
RESULTS
Patient Characteristics
Figure 1 describes patient inclusion in our study. Of 480 enrolled patients, 16 were lost to follow-up during the study period. For the remaining 464 patients, the mean AE SD age was 79.7 AE 4.0 years, and 65% were male (Table 1) . About 38% (n = 178) had an aggressive blood cancer. Approximately 65% (n = 302) had a Charlson score of 3 or higher. Of patients, 11.4% (n = 53) reported at least one dependency in ADLs, and 26.7% (n = 124) reported at least one dependency in iADLs. Most patients with ADL dependency also had iADL dependency (47/53), whereas the majority of patients with iADL dependency were still independent in their ADLs (77/124). Participants were followed for a mean AE SD of 13.8 AE 9.5 months. Of the 464 patients followed, 12 had incomplete treatment data, which left 452 patients for multivariable analyses. Of patients, 44.9% (n = 203) were treated prior to their initial consultation in our clinics and enrollment in our study. At the time of enrollment or starting within the 3 months after, 46.7% (n = 211) patients received intensive chemotherapy, 13.5% (n = 61) received reduced intensity regimens, and 39.8% (n = 180) were on supportive management. About a quarter of patients (24.6%) died during follow-up. Among the subset of patients identified and followed for ED visits and unplanned hospitalizations (n = 318), 16 .7% (n = 53) had at least one ED visit and 18.9% (n = 60) had at least one unplanned hospitalization. Of the 94 total hospitalizations, the five most common primary diagnoses were pneumonia (n = 13, 13.8%), fever (n = 8, 8.5%), sepsis (n = 6, 6.4%), pain (n = 6, 6.4%), and congestive heart failure (n = 5, 5.3%). Table 2 ). These independent associations between iADL dependency and acute-care utilization were maintained in our sensitivity analysis (Table SS1) . ADL dependency was not associated with care utilization.
Association of Functional Dependency With Survival and Care Utilization
Dependency in iADLs and Survival
Of the tested interactions, iADL dependency and cancer aggressiveness demonstrated a significant interaction in their effect on survival (Figure 2 , test for interaction P < .05). Patients with both aggressive cancer and iADL dependency had a significantly lower median survival (10 vs greater than 34 months) and over a three-fold higher hazard of death compared to those with aggressive cancers who were independent in their iADLs (HR = 3.61 [95% CI = 1.83-7.13]). There was no interaction between iADL dependency and reported depression, loneliness, or marital status (all interaction P > .05).
In Table SS2 ). Aside from delayed memory, each of these impaired geriatric domains was independently associated with higher odds of being iADL dependent (Table SS3) .
DISCUSSION
In our population of adults aged 75 years and older with hematologic malignancies, iADL dependency was associated with higher risk of ED visits, hospitalizations, and death-independently of age, comorbidity, cancer aggressiveness, and treatment intensity. iADL dependency increased risk of death in a dose-dependent manner, and individual dependencies (shopping, meals, and housework) each contributed to higher risk of mortality. iADL dependency interacted with cancer aggressiveness to affect mortality; however, iADL dependency did not interact with reported depression, loneliness, and marital status.
Prior smaller studies have suggested that functional impairment impacts survival in populations with blood cancers. [29] [30] [31] In addition, ADLs and iADLs are included in the International Myeloma Working Group's frailty index based on their predictive ability in older patients with multiple myeloma, 32, 33 although a recent analysis suggests this index can miss some robust older patients. 34 Impairment in function has also been shown to predict survival in previous studies of older patients with solid tumors. [8] [9] [10] [35] [36] [37] Our study demonstrates the importance of iADL assessment in a population of different hematologic malignancies, showing that older adults impaired in their iADLs are more vulnerable not only to worse survival but also to increased care utilization. The latter is a significant outcome that is understudied in older adults with blood cancers, as unplanned hospitalizations represent both an adverse outcome as well as an important contributor to physical dysfunction and mortality in frail older patients. In our population, iADL dependency was associated with adverse outcomes, whereas ADL dependency was not. Nearly all patients with ADL dependency also had iADL dependency, but the majority of patients with iADL dependency were independent in their ADLs. Since it typically represents more severe functional impairment, we expected ADL dependency to also be linked to survival. 20, 40 The lack of association in our study may be due to selection bias, with a relatively low number of patients with ADL dependency. Klepin and colleagues came to a similar conclusion when interpreting their finding that patient-reported function was not associated with survival in a younger cohort of AML patients highly selected for induction chemotherapy. 15 Indeed, our sensitivity analysis showed that grouping patients with only ADL dependency together with patients with dual ADL/iADL dependency demonstrated a significant association with mortality. Alternatively, due to their more obvious deficits, patients with more severe functional impairment may have actually had more supports in place than patients with only iADL dependency.
38,39
Our data argue that for older patients with blood cancers seeking treatment at a tertiary center, iADL rather than ADL assessment is more sensitive for detecting deficits impacting prognosis. Limitations in iADLs can be difficult Figure 2 . Kaplan-Meier curves depicting association between instrumental activity of daily living (iADL) dependency and survival, stratified by indolent (A) and aggressive (B) malignancies. Numbers in blue and red above each time point refer to the remaining iADL-dependent and iADL-independent patients at risk, respectively (ie, those at each time point who are still alive and have not been censored).
to ascertain; however, they often speak to the specific higherorder functioning needed to adhere to therapies and/or overcome complications associated with hematologic malignancies. Leukemia, multiple myeloma, and lymphoma have complex, extended regimens that require an ability to carefully navigate the healthcare system. The interaction seen between iADL dependency and aggressive malignancies suggests such higher-order functioning is even more critical to survive the most severe blood cancers.
Our analysis suggests specific interventions for patients with blood cancers and impaired iADLs beyond addressing the individual iADL dependencies themselves. In our cohort, probable executive dysfunction, multimorbidity, physical dysfunction, and psychosocial vulnerability were each independently associated with a higher risk of being dependent in one or more iADLs-consistent with other nononcologic populations of older adults. [41] [42] [43] Geriatric assessment not only detects these vulnerabilities, but can guide interventions aimed at reversing them. 44, 45 First, identifying cognitive impairment-found in our prior work to be prevalent in our population and itself linked to survival 17 -provides an opportunity to treat reversible contributors (eg, sensory impairment 46 ) and to recommend social and safety supports. 47 Second, physical dysfunction could be due to deconditioning and/or sarcopenia that can be partially or wholly reversed with physical therapy, structured exercise, or boosting nutrition. 48 Third, identifying multimorbidity signals the need to make sure diseases other than an older patient's cancer are optimized and not adversely interacting with the cancer and its treatment. 49 Finally, identifying depression or social isolation might prompt a referral to a social worker who can help with counseling or providing community resources. 50 Our analysis has limitations. First, patients may have underreported or overreported their functional status due to social desirability bias or cognitive impairment; however, self-reported ADLs and iADLs are the standard of functional assessment in older adults, and our geriatrician-trained research staff monitored the completion of the questionnaire and allowed input from families when patients requested. Second, since the analysis of which geriatric assessment domain impairments were associated with iADL dependency was cross-sectional, determining causal relationships and directionality was limited (eg, whether physical dysfunction led to iADL dependency or vice versa). Third, our assessment for care utilization may have been affected by competing risks due to early deaths and was limited because we had to restrict it to those followed in our care system (to reduce measurement error resulting from unobserved hospitalizations in those followed outside our system). Fourth, our single-item questions for depression and loneliness may not have had the sensitivity or reliability to fully capture these constructs. Finally, our study featured geriatric screenings performed on patients at a single tertiary institution and may not generalize to other settings.
Taken together, our findings suggest that older adults with hematologic malignancies and iADL dependency experience higher mortality and increased acute-care utilization, strongly supporting the current ASCO recommendation that patients with cancer have formal assessment of iADLs as part of routine oncology care. As with many analyses, our current work answers some questions for older patients with blood cancers while at the same time suggesting others. Next steps should focus on answering these, including who should best provide iADL assessments in the context of national resource restraints, and the dual role of function not only as a predictor of survival and care utilization but also as an outcome that itself must be optimized. Figure S1 . Instrumental activity of daily living (iADL) dependency emerges from cognitive impairment, physical dysfunction, and/or multimorbidity and mediates these domains' effects on mortality and care utilization. Solid arrows pointing from each geriatric domain impairment to iADL dependency represent their individual contribution to iADL dependency. Dashed arrows pointing directly to mortality and care utilization represent each domain impairment's effects not mediated by iADL dependency. Psychosocial vulnerability both contributes to iADL dependency as well as modifies the effects that geriatric domains have on iADL dependency and that iADL dependency has on outcomes. 
